Note: Ingredients listed on restricted chemical lists
EC/CAS
200-385-7/58-55-9
Name of the chemical
Theophyllin; 1,3-Dimethyl-3,7-dihydro-1H-purin-2,6-dion (2022/692)
Concentration
N/A
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
EC/CAS
201-070-7/77-93-0
Name of the chemical
citric acid, triethyl ester
Concentration
N/A
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2021-11-19
Product name
THEOVENT TABLETS 300
Product Synonyms
THEOVENT TABLETS 300 MG * THEOVENT 300 PROLONGATUM TABLETKI 300 MG *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 3 H301 - Toxic if swallowed. Hazard summary Toxic if swallowed. Prolonged exposure may cause chronic effects. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
MICROCRYSTALLINE CELLULOSE, TALC, NON-ASBESTOS FORM, THEOPHYLLINE, TRIETHYL CITRATE
Signal word
Danger
Hazard statements
H301 Toxic if swallowed.
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTRE/doctor/. P330 Rinse mouth. P321 Specific treatment (see this label).
Storage
P405 Store locked up.
Disposal
Not available.
Supplemental label elements
32.59 % of the mixture consists of component(s) of unknown acute oral toxicity. 37.59 % of the mixture consists of component(s) of unknown acute dermal toxicity. 32.03 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 38.68 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 38.68 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
